DOMENICA
Trial Description:
Randomized phase III trial in MMR deficient endometrial cancer patients comparing chemotherapy alone versus Dostarlimab in first line advanced/metastatic setting
Lead Cooperative Group:
Trial Number:
Disease Site:
Endometrial
Trial Status:
Recruiting
Contact person:
fjoly